Chardan Capital Markets Downgrades Seres Therapeutics (MCRB) to Neutral May 8, 2025 05:06AM
Seres Therapeutics to Present at Chardan Metagenomics and Microbiome Medicines Summit Feb 22, 2022 07:00AM
Seres Therapeutics (MCRB) PT Lowered to $16 at Chardan Capital Markets Jul 23, 2021 07:34AM
Chardan Capital Markets Upgrades Seres Therapeutics (MCRB) to Buy Mar 5, 2021 08:15AM
Seres Therapeutics to Participate in Upcoming Virtual Investor Conferences Feb 26, 2021 08:00AM


Sep 18, 2020 07:20AM UPDATE: Chardan Capital Markets Downgrades Seres Therapeutics (MCRB) to Neutral
Aug 10, 2020 04:47PM Seres Therapeutics (MCRB) PT Raised to $32.50 at Chardan Capital Markets
Mar 15, 2020 03:00PM Seres Therapeutics to Virtually Present at the Chardan Microbiome Medicines Summit
Mar 5, 2019 04:00PM Seres Therapeutics to Present at Three Upcoming March Conferences
Oct 22, 2018 06:27AM UPDATE: Chardan Capital Markets Starts Seres Therapeutics (MCRB) at Buy